Why the study?
Acquired von Willebrand syndrome develops in patients receiving temporary mechanical circulatory support, but its prognostic implication remains unknown.
Does advanced acquired von Willebrand syndrome (AVWS) reduce 30-day survival in patients receiving temporary mechanical circulatory support?
Does advanced acquired von Willebrand syndrome (AVWS) reduce 30-day survival in patients receiving temporary mechanical circulatory support?
Advanced acquired von Willebrand syndrome is associated with significantly lower short-term survival in patients receiving temporary mechanical circulatory support.
Answers are grounded in this paper and cite their sources.
Advanced AVWS may flag higher 30-day mortality risk on temporary MCS; hypothesis-generating and requires prospective validation.
Background and Objectives: Acquired von Willebrand syndrome (AVWS) develops not only in patients with durable ventricular assist devices but also in patients receiving temporary mechanical circulatory support (MCS). However, its prognostic implication remains unknown. Materials and Methods: Patients who received temporary MCS in our institute between August 2018 and September 2021 were included in this prospective study and the von Willebrand factor multimer analyses were performed following the initiation of temporary MCS supports. The von Willebrand factor large-multimer index was calculated as a normalized ratio of large-multimer proportion among total von Willebrand factor. Association between the large-multimer index and the 30-day survival was investigated. Results: A total of 31 patients (69 years old, 52% men) were included. Median large-multimer index was 63.0% (56.9%, 75.6%). The index was lowest in patients with extracorporeal membrane oxygenation than those receiving support from other devices. A lower index (<59.9%) was associated with lower 30-day survival (41.7% versus 94.7%, p = 0.001) with an odds ratio 0.044 (95% confidence interval 0.002–0.805, p = 0.035) adjusted for other potential confounders. Conclusions: An advanced AVWS was associated with lower short-term survival in patients with temporary MCS. The clinical implication of AVWS-guided temporary MCS management remains the next concern.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: